The Phoenix Mills Ltd. (PDF)
Trending Sector
Current IPOs
Closed IPOs
Listed IPOs
IPO Performers
CAGR Calculator
SIP Calculator
Retirement Planning Calculator
Adani Ports and SEZ
Tatva Chintan Pharma Share Price
Tatva Chintan Pharma (INR)853.35-12 (-1.4%) 
Exchange ScripsBSE543321NSETATVAISININE0GK401011
Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks
Trendline of performance -
Tatva Chintan Pharma Performance
Market performance
Open price869.9
High889.05
Volumes16277
Prev Close853.35
Low850.05
Closing date2025-01-10
Historical performance
1 Year High1523.00
3 Year High2958.65
5 Year High2977.80
1 Year Low788.50
3 Year Low788.50
5 Year Low788.50
Tatva Chintan Pharma Fundamentals
Company Valuation
Market Cap (₹Cr)
2021
Face Value (₹)
10
P/E Ratio
65.76
Dividend Yield
0.02 %
Tatva Chintan Pharma Investment Returns
1 Year
-43.7%
3 Years
-67.5%
5 Years
N/A
10 Years
N/A
Tatva Chintan Pharma Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 876.57 | Bearish |
| 10-DMA | 874.63 | Bearish |
| 20-DMA | 865.94 | Bearish |
| 50-DMA | 866.03 | Bearish |
| 100-DMA | 926.04 | Bearish |
| 200-DMA | 1018.68 | Bearish |
Shareholding Pattern
| Field | Dec-2024 | Sep-2024 | Jun-2024 | Mar-2024 | Dec-2023 |
|---|---|---|---|---|---|
| Promoters | 11 | 11 | 11 | 11 | 11 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 11 | 11 | 11 | 11 | 11 |
| Public Investors | 78998 | 79612 | 73901 | 73719 | 74508 |
| Government | --- | --- | --- | --- | --- |
Tatva Chintan Pharma Financials
Below figures are in Rs. Crores
| Particulars | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
| Other Income | 75 | 57 | 90 | 52 |
| Operating Profit | 759 | 665 | 1175 | 719 |
| Interest | 67 | 86 | 52 | 44 |
| Depreciation | 256 | 96 | 82 | 67 |
| Profit Before Tax | 436 | 448 | 1041 | 607 |
| Consolidated Net Profit | 304 | 455 | 959 | 523 |
| Adjusted EPS | 13 | 21 | 43 | 26 |
Balance Sheet
Below figures are in Rs. Crores
| Particulars | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
| Share Capital | 234 | 222 | 222 | 201 |
| Total Reserves | 7137 | 4926 | 4509 | 1459 |
| Minority Interest | --- | --- | --- | --- |
| Total Non-Current Liabilities | -103 | -110 | 51 | 308 |
| Total Liabilities | 8138 | 7443 | 6493 | 3252 |
| Capital Work in Progress | 729 | 2307 | 515 | 98 |
| Total Assets | 8138 | 7443 | 6493 | 3252 |
Cash Flow
Below figures are in Rs. Crores
| Particulars | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
| Cash Flow from Operating Activities | 980 | 278 | 202 | 197 |
| Cash Flow from Investing Activities | -1205 | -1011 | -1967 | -207 |
| Cash Flow from Financing Activitie | 305 | 378 | 2350 | -47 |
| Net Cash Inflow / Outflow | 80 | -356 | 586 | -57 |
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 65.76.
- 3Y Stock Price CAGR of the stock is -32.2.
- The stock has a beta of 0.3.
- In the last financial year, the company had an EBITDA of ₹759 Million.
- The company generated revenue of ₹3935 Million in the previous financial year.
Tatva Chintan Pharma
853.35-12 (-1.4%)
Investment Amount: ₹ 148670
Current Value: ₹ 85335
Performance: -42.6%
P/L: ₹ -63335
Top Gainers
| Symbol | Change% |
|---|---|
| NURECA | 380.7(18%) |
| CUBEXTUB | 96.84(16%) |
| MAZDA | 1969.9(14%) |
| ATLASCYCLE | 112.81(10%) |
| DNAMEDIA | 6.99(10%) |
Top Losers
| Symbol | Change% |
|---|---|
| GTPL | 130.53(-11%) |
| GRWRHITECH | 4286.15(-10%) |
| JAICORPLTD | 173(-10%) |
| AWL | 291.1(-10%) |
| SPANDANA | 405.8(-10%) |
| DISHTV | 8.86(-10%) |
| HARRMALAYA | 284.45(-9%) |
| KAMDHENU | 46.4(-9%) |
Similar stocks
Announcing Stock of the Month!
